Some preliminary data indicates that inhibiting key kinases from the NF-κB pathway impacts glycolysis/OXPHOS within glioblastoma cells and negatively impacts the growth of tumors in mouse xenograft models under a ketogenic diet [84]. Here, NFKB1 is linked to glioblastoma.